| 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | affects expression | ISO | RGD:1564008 | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the expression of DACT1 mRNA | CTD | PMID:19414516 |
| 1-chloro-2,4-dinitrobenzene | decreases expression | EXP | | 6480464 | Dinitrochlorobenzene results in decreased expression of DACT1 mRNA | CTD | PMID:18242016 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1348421 | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of DACT1 mRNA | CTD | PMID:17404688 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of DACT1 mRNA | CTD | PMID:21570461 |
| 3-methylcholanthrene | decreases expression | EXP | | 6480464 | Methylcholanthrene results in decreased expression of DACT1 mRNA | CTD | PMID:20713471 |
| 4-(ethoxymethylene)-2-phenyloxazol-5-one | decreases expression | EXP | | 6480464 | Oxazolone results in decreased expression of DACT1 mRNA | CTD | PMID:18242016 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:1348421 | 6480464 | [decitabine affects the methylation of DACT1 promoter] which affects the expression of DACT1 mRNA | CTD | PMID:18538736 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:1348421 | 6480464 | [decitabine affects the methylation of DACT1 promoter] which affects the expression of DACT1 mRNA | CTD | PMID:18538736 PMID:18538736 |
| 8-bromo-3',5'-cyclic AMP | decreases expression | ISO | RGD:1348421 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of DACT1 mRNA | CTD | PMID:22079614 |
| aflatoxin B1 | affects expression | ISO | RGD:1348421 | 6480464 | Aflatoxin B1 affects the expression of DACT1 protein | CTD | PMID:20106945 |
| aflatoxin B1 | increases expression | ISO | RGD:1348421 | 6480464 | Aflatoxin B1 results in increased expression of DACT1 mRNA | CTD | PMID:22100608 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1348421 | 6480464 | Tretinoin results in increased expression of DACT1 mRNA | CTD | PMID:21934132 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1564008 | 6480464 | Tretinoin results in increased expression of DACT1 mRNA | CTD | PMID:20488242 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of DACT1 mRNA | CTD | PMID:20713471 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of DACT1 mRNA | CTD | PMID:20713471 PMID:21569818 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of DACT1 mRNA | CTD | PMID:21569818 PMID:20713471 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of DACT1 mRNA | CTD | PMID:19770486 |
| bisphenol A | affects expression | ISO | RGD:1348421 | 6480464 | bisphenol A affects the expression of DACT1 mRNA | CTD | PMID:20170705 |
| calciol | increases expression | EXP | | 6480464 | Cholecalciferol results in increased expression of DACT1 mRNA | CTD | PMID:17170073 |
| carbamazepine | affects expression | EXP | | 6480464 | Carbamazepine affects the expression of DACT1 mRNA | CTD | PMID:22634333 |
| choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of DACT1 gene | CTD | PMID:20938992 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of DACT1 mRNA | CTD | PMID:19770486 |
| dasatinib (anhydrous) | increases expression | ISO | RGD:1348421 | 6480464 | dasatinib results in increased expression of DACT1 mRNA | CTD | PMID:20579391 |
| dibutyl phthalate | decreases expression | ISO | RGD:1564008 | 6480464 | Dibutyl Phthalate results in decreased expression of DACT1 mRNA | CTD | PMID:21266533 |
| elemental selenium | decreases expression | ISO | RGD:1348421 | 6480464 | Selenium results in decreased expression of DACT1 mRNA | CTD | PMID:19244175 |
| folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of DACT1 gene | CTD | PMID:20938992 |
| L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of DACT1 gene | CTD | PMID:20938992 |
| progesterone | decreases expression | ISO | RGD:1348421 | 6480464 | Progesterone results in decreased expression of DACT1 mRNA | CTD | PMID:17404688 |
| progesterone | multiple interactions | ISO | RGD:1348421 | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of DACT1 mRNA | CTD | PMID:17404688 |
| raloxifene | multiple interactions | ISO | RGD:1348421 | 6480464 | [Raloxifene co-treated with ESR2 protein] results in increased expression of DACT1 mRNA | CTD | PMID:19059307 |
| selenium atom | decreases expression | ISO | RGD:1348421 | 6480464 | Selenium results in decreased expression of DACT1 mRNA | CTD | PMID:19244175 |
| tamoxifen | multiple interactions | ISO | RGD:1348421 | 6480464 | [Tamoxifen co-treated with ESR2 protein] results in increased expression of DACT1 mRNA | CTD | PMID:19059307 |
| toluene 2,4-diisocyanate | decreases expression | EXP | | 6480464 | Toluene 2,4-Diisocyanate results in decreased expression of DACT1 mRNA | CTD | PMID:18242016 |